A $7.4 Billion Fund Dumps These 3 Stocks

Michael Douglass • 6 minute read
Reviewed by: Michael Douglass
Last updated Nov 19, 2026

geralt from pixabay and Deepanker Verma from Pexels via Canva

Key Takeaways

  • SurgoCap Partners, a firm managing $7.35 billion, sold all of its Alphabet, Corning and Argan shares in the third quarter, its latest 13F shows.
  • The numbers back the Argan sale best, since its backlog is shrinking and only six analysts stand behind its 88% upside.
  • The fund also opened a Microsoft position and added 53% to McKesson, now its second-largest holding.
  • Alphabet looks like the best buy of the three at about 20x forward earnings, below its long-run average.

SurgoCap Partners, which manages $7.35 billion, sold out of three stocks that made up more than a fifth of its 13F stocks at midyear. Its 13F for the quarter ended Sept. 30, filed Nov. 16, shows no shares of Alphabet (GOOG), Corning (GLW) or Argan (AGX), and $3.04 billion of US stocks across 11 positions.

It wasn’t all selling. The fund opened a stake in Microsoft (MSFT) and added to McKesson (MCK), now its second-largest holding.

Alphabet was the biggest exit

At June 30, the fund held 966,080 Alphabet shares worth $341 million, 11.0% of its 13F stocks. The stock is down 21% since then and sits 31% below its 52-week high.

The worry is the spending. In July, Alphabet guided to $195 billion to $205 billion of capital spending this year, more than double 2025’s $91.4 billion, and consensus has free cash flow turning negative in 2027. Analysts have also cut 2026 normalized EPS to $13.46 from $14.90. And Altimeter’s Brad Gerstner thinks OpenAI now handles 25% of Google’s daily search volume (Altimeter is a major OpenAI shareholder).

The average target rose from about $310 a year ago to nearly $429 in July, and it has eased since:

Line chart from TIKR of Alphabet's analysts' consensus (mean) price target, $ per share, last year.
Alphabet (GOOG): analysts’ consensus (mean) price target, $ per share, last year (TIKR)

The average target from 58 analysts, $400, sits 43% above the last close. And at about 20x forward earnings, Alphabet trades below its 23x average since 2014.

TIKR tracks 60 analysts on Alphabet. How many say “Buy”?

See the full breakdown of Buy, Hold, and Sell ratings on Alphabet, along with Wall Street’s revenue and earnings estimates, all in one place. More than 500,000 investors use TIKR to research stocks like this one. See Alphabet’s Analyst Ratings

Corning lost more than half

The fund held 797,181 Corning shares worth $204 million at June 30, 6.6% of its 13F stocks. Corning is down 58% since then.

The business has held up better than the stock. Second-quarter core EPS, Corning’s adjusted measure, rose 30%, but its third-quarter guide of $4.9 billion to $5.0 billion of core sales fell short of expectations. In September, Corning signed an agreement to issue up to $2 billion of new shares from time to time. Then third-quarter core sales came in at $5.08 billion, putting its annualized sales run rate at $20.3 billion, past its $20 billion target for the end of 2026.

Analysts have trimmed their targets far less than the stock fell. The average more than doubled from about $93 a year ago to $215 in July, and it has come down to $172 since:

Line chart from TIKR of Corning's analysts' consensus (mean) price target, $ per share, last year.
Corning (GLW): analysts’ consensus (mean) price target, $ per share, last year (TIKR)

That average, from 19 analysts, sits 59% above the last close. Corning trades at about 26x forward earnings, and that share agreement would dilute holders if it’s used.

Argan’s backlog is shrinking

Argan was the smallest exit: 149,983 shares worth $120 million at June 30, 3.9% of the fund’s 13F stocks. It’s down 62% since.

Its fiscal second quarter, which ended July 31, brought record revenue of $384 million, up 61.5% from a year earlier. But its backlog stood at about $2.5 billion at July 31, down from about $2.9 billion at Jan. 31, and management pointed to weaker results on some Industrial and Teledata projects. The board still raised the quarterly dividend 40%, to $0.70 a share from $0.50.

Argan’s average target, from six analysts, more than doubled from $262 to nearly $680 in June before easing to $570.50:

Line chart from TIKR of Argan's analysts' consensus (mean) price target, $ per share, last year.
Argan (AGX): analysts’ consensus (mean) price target, $ per share, last year (TIKR)

That’s 88% above the last close, at about 22x forward earnings. But those targets predate the stock’s October and November slide, and the lowest of them, $273, is already below the last close.

It bought Microsoft and added to McKesson

The same 13F shows a new Microsoft position of 573,423 shares worth $294 million, 9.7% of its 13F stocks. The fund also added 53% to McKesson, to 577,584 shares worth $493 million, 16.2% of its 13F stocks.

McKesson is up 27% since Sept. 30, with the average target just 7% above the last close. Microsoft is down 0.9% since Sept. 30, and at about 24x forward earnings it trades below its 26x average since 2014, with the average target 25% higher.

The Argan sale has the numbers on its side

The numbers back the Argan exit best. A shrinking backlog is a real problem for a company priced on growth, and six analysts make a thin base for an 88% upside figure. Corning’s is a closer call: its sales are running ahead of plan, but 26x forward earnings with a possible share sale is no bargain.

The numbers back Alphabet’s sale least. At 20x forward earnings, below its long-run average, with 58 analysts’ targets averaging 43% above the price, it’s the one of the three I’d buy right now. The risk is the spending: a 2027 capital budget well above the $308 billion analysts expect would make that discount look deserved.

Alphabet’s fourth-quarter report, expected in early February, should carry the next word on 2027 spending, and Argan’s next report will show whether its backlog held near $2.5 billion. The fund’s next 13F, due by mid-February, will show whether it bought any of the three back by Dec. 31.

So what is Alphabet stock actually worth?

TIKR lets you forecast the future price of any stock in less than a minute. Just enter a few assumptions into TIKR’s valuation model and see what Alphabet could be worth. Start from Wall Street consensus estimates, or adjust the inputs to reflect your own view of the business. It’s free to use.

Value Alphabet for free

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!

Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.

Sign Up for FREENo credit card required